AFP and hepatocellular carcinoma: In a similar study, Park et al. (2014) explored the role of PIVKA-II and AFP in predicting non-surgical treatment outcomes in advanced HCC and found that a combination of biomarkers predicted tumour responses to local treatments better than AFP alone.